NYSE:CAH - Cardinal Health Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$53.13 -0.20 (-0.38 %)
(As of 05/22/2018 01:50 AM ET)
Previous Close$53.13
Today's Range$53.03 - $54.07
52-Week Range$50.79 - $80.37
Volume3.15 million shs
Average Volume3.20 million shs
Market Capitalization$16.57 billion
P/E Ratio9.84
Dividend Yield3.40%
Beta1.06

About Cardinal Health (NYSE:CAH)

Cardinal Health logoCardinal Health, Inc. operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers. This segment also operates nuclear pharmacies and manufacturing facilities that manufacture, prepare, and deliver radiopharmaceuticals, as well as operates direct-to-patient specialty pharmacies; offers logistics, marketing, and other services; and repackages generic pharmaceuticals and over-the-counter healthcare products. The company's Medical segment manufactures and sources medical, surgical, and laboratory products, including cardiovascular and endovascular products; wound care products; surgical drapes, gowns, and apparel; exam and surgical gloves; fluid suction and collection systems; and incontinence, enteral feeding, urology, operating room supply, electrode and needle, and syringe and sharps disposal product lines. It also distributes medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers, as well as to patients in the home; and assembles and sells sterile and non-sterile procedure kits. In addition, it offers supply chain services to healthcare providers; and post-acute care management, and transition services and software to hospitals, other healthcare providers, and payers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

Receive CAH News and Ratings via Email

Sign-up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:CAH
CUSIP14149Y10
Phone614-757-3033

Debt

Debt-to-Equity Ratio1.20
Current Ratio1.10
Quick Ratio0.54

Price-To-Earnings

Trailing P/E Ratio9.84
Forward P/E Ratio10.82
P/E Growth1.34

Sales & Book Value

Annual Sales$129.98 billion
Price / Sales0.13
Cash Flow$7.7112 per share
Price / Cash6.89
Book Value$21.62 per share
Price / Book2.46

Profitability

EPS (Most Recent Fiscal Year)$5.40
Net Income$1.29 billion
Net Margins1.26%
Return on Equity23.39%
Return on Assets4.04%

Miscellaneous

Employees28,000
Outstanding Shares310,680,000

Cardinal Health (NYSE:CAH) Frequently Asked Questions

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health declared a quarterly dividend on Wednesday, May 9th. Shareholders of record on Monday, July 2nd will be given a dividend of $0.476 per share on Sunday, July 15th. This represents a $1.90 annualized dividend and a yield of 3.58%. The ex-dividend date is Friday, June 29th. This is a boost from Cardinal Health's previous quarterly dividend of $0.46. View Cardinal Health's Dividend History.

How will Cardinal Health's stock buyback program work?

Cardinal Health announced that its Board of Directors has authorized a stock buyback plan on Thursday, February 8th 2018, which authorizes the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company's board believes its shares are undervalued.

How were Cardinal Health's earnings last quarter?

Cardinal Health (NYSE:CAH) released its quarterly earnings results on Monday, November, 6th. The company reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. The business had revenue of $32.64 billion for the quarter, compared to analyst estimates of $33.48 billion. Cardinal Health had a net margin of 1.26% and a return on equity of 23.39%. The company's revenue for the quarter was up 1.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.24 earnings per share. View Cardinal Health's Earnings History.

When is Cardinal Health's next earnings date?

Cardinal Health is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Cardinal Health.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health issued an update on its FY18 earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $4.85-4.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.42.

What price target have analysts set for CAH?

15 equities research analysts have issued 1-year target prices for Cardinal Health's shares. Their forecasts range from $55.00 to $85.00. On average, they anticipate Cardinal Health's stock price to reach $69.7692 in the next twelve months. View Analyst Ratings for Cardinal Health.

Who are some of Cardinal Health's key competitors?

Who are Cardinal Health's key executives?

Cardinal Health's management team includes the folowing people:
  • Mr. George S. Barrett, Exec. Chairman (Age 63)
  • Mr. Michael C. Kaufmann, CEO & Director (Age 55)
  • Mr. Craig S. Morford, Chief Legal & Compliance Officer (Age 59)
  • Mr. Jon L. Giacomin, Chief Exec. Officer of Medical Segment (Age 53)
  • Mr. Donald M. Casey Jr., Chief Exec. Officer of Medical Segment (Age 58)

Has Cardinal Health been receiving favorable news coverage?

News articles about CAH stock have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research group rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardinal Health earned a news sentiment score of 0.10 on Accern's scale. They also gave news headlines about the company an impact score of 47.56 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.73%), Barrow Hanley Mewhinney & Strauss LLC (5.98%), American International Group Inc. (2.51%), Boston Partners (1.94%), Franklin Resources Inc. (1.81%) and Northern Trust Corp (1.37%). Company insiders that own Cardinal Health stock include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

Which institutional investors are selling Cardinal Health stock?

CAH stock was sold by a variety of institutional investors in the last quarter, including Element Capital Management LLC, Franklin Resources Inc., JPMorgan Chase & Co., American Century Companies Inc., BlackRock Inc., Thompson Siegel & Walmsley LLC, LSV Asset Management and DekaBank Deutsche Girozentrale. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

Which institutional investors are buying Cardinal Health stock?

CAH stock was bought by a variety of institutional investors in the last quarter, including Boston Partners, Pzena Investment Management LLC, Point72 Asset Management L.P., Schwab Charles Investment Management Inc., Barrow Hanley Mewhinney & Strauss LLC, Russell Investments Group Ltd., Wedge Capital Management L L P NC and Roystone Capital Management LP. View Insider Buying and Selling for Cardinal Health.

How do I buy shares of Cardinal Health?

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardinal Health's stock price today?

One share of CAH stock can currently be purchased for approximately $53.13.

How big of a company is Cardinal Health?

Cardinal Health has a market capitalization of $16.57 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

How can I contact Cardinal Health?

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-3033 or via email at [email protected]


MarketBeat Community Rating for Cardinal Health (CAH)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  532 (Vote Outperform)
Underperform Votes:  366 (Vote Underperform)
Total Votes:  898
MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe CAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CAH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cardinal Health (NYSE:CAH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
15 Wall Street analysts have issued ratings and price targets for Cardinal Health in the last 12 months. Their average twelve-month price target is $69.7692, suggesting that the stock has a possible upside of 31.32%. The high price target for CAH is $85.00 and the low price target for CAH is $55.00. There are currently 2 sell ratings, 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.132.072.132.20
Ratings Breakdown: 2 Sell Rating(s)
9 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
10 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
12 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
10 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $69.7692$74.3333$74.9091$74.50
Price Target Upside: 31.32% upside16.71% upside11.36% upside29.54% upside

Cardinal Health (NYSE:CAH) Consensus Price Target History

Price Target History for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/7/2018MizuhoSet Price TargetHold$61.00LowView Rating Details
5/5/2018Leerink SwannSet Price TargetBuy$65.00LowView Rating Details
5/4/2018Royal Bank of CanadaSet Price TargetHold$62.00HighView Rating Details
5/4/2018Jefferies GroupSet Price TargetHold$55.00HighView Rating Details
4/16/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$74.00 ➝ $68.00MediumView Rating Details
4/2/2018ArgusUpgradeHold ➝ Buy$85.00HighView Rating Details
2/27/2018Bank of AmericaInitiated CoverageUnderperform ➝ Underperform$69.00LowView Rating Details
1/17/2018Robert W. BairdReiterated RatingHold$80.00MediumView Rating Details
1/4/2018Evercore ISIInitiated CoverageIn ➝ In-Line$67.00MediumView Rating Details
12/4/2017Deutsche BankInitiated CoverageHold$64.00HighView Rating Details
11/20/2017Morgan StanleyDowngradeEqual Weight ➝ UnderweightN/AView Rating Details
10/12/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
10/10/2017CowenUpgradeBuy$74.00N/AView Rating Details
8/9/2017UBSReiterated RatingNeutral$79.00 ➝ $76.00MediumView Rating Details
8/3/2017Credit Suisse GroupLower Price TargetOutperform$87.00 ➝ $81.00MediumView Rating Details
4/28/2017Tigress FinancialInitiated CoverageNeutral ➝ NeutralLowView Rating Details
4/19/2017William BlairDowngradeOutperform ➝ Market PerformLowView Rating Details
10/10/2016Cleveland ResearchDowngradeBuy ➝ NeutralN/AView Rating Details
9/16/2016Goldman SachsDowngradeBuy ➝ Neutral$90.00 ➝ $83.00N/AView Rating Details
8/3/2016CitigroupBoost Price TargetNeutral$87.00 ➝ $93.00N/AView Rating Details
6/20/2016FBR & CoReiterated RatingBuyN/AView Rating Details
6/1/2016Raymond JamesDowngradeOutperform ➝ Market PerformN/AView Rating Details
(Data available from 5/22/2016 forward)

Earnings

Cardinal Health (NYSE:CAH) Earnings History and Estimates Chart

Earnings by Quarter for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) Earnings Estimates

2018 EPS Consensus Estimate: $5.10
2019 EPS Consensus Estimate: $6.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.99$1.18$1.08
Q2 20183$1.10$1.21$1.16
Q3 20183$1.43$1.78$1.55
Q4 20183$1.23$1.48$1.31
Q1 20192$1.40$1.40$1.40
Q2 20192$1.59$1.69$1.64
Q3 20192$1.48$1.73$1.61
Q4 20192$1.58$1.64$1.61

Cardinal Health (NYSE CAH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/31/2018$0.93N/AView Earnings Details
2/8/2018Q2 2018$1.14$1.31$34.6276 billion$35.1860 billionViewN/AView Earnings Details
11/6/2017Q1 2018$1.00$1.09$33.4831 billion$32.6410 billionViewN/AView Earnings Details
8/2/2017Q4 2017$1.24$1.31$32.7337 billion$32.9660 billionViewListenView Earnings Details
5/1/2017Q3 2017$1.4580$1.53$32.3016 billion$31.8210 billionViewListenView Earnings Details
2/7/2017Q217$1.23$1.34$33.63 billion$33.10 billionViewListenView Earnings Details
10/31/2016Q117$1.21$1.24$31.12 billion$32.00 billionViewListenView Earnings Details
8/2/2016Q416$1.13$1.14$31.06 billion$31.40 billionViewN/AView Earnings Details
4/28/2016Q316$1.33$1.43$30.54 billion$30.70 billionViewListenView Earnings Details
2/1/2016Q216$1.26$1.30$29.23 billion$31.40 billionViewN/AView Earnings Details
11/2/2015Q116$1.10$1.38$27.19 billion$28.10 billionViewN/AView Earnings Details
7/30/2015Q415$0.99$1.00$26.05 billion$27.50 billionViewListenView Earnings Details
4/30/2015Q3$1.16$1.19$24.3979 billion$25.3750 billionViewN/AView Earnings Details
1/29/2015Q215$1.11$1.20$23.43 billion$25.50 billionViewN/AView Earnings Details
10/30/2014Q115$0.96$1.00$22.43 billion$24.07 billionViewN/AView Earnings Details
8/4/2014Q414$0.81$0.83$21.88 billion$2.90 billionViewN/AView Earnings Details
5/1/2014Q314$1.01$1.01$21.72 million$21.40 millionViewN/AView Earnings Details
1/31/2014Q214$0.84$0.79$20.74 billion$22.20 billionViewN/AView Earnings Details
10/31/2013Q114$0.86$1.10$22.73 billion$24.50 billionViewN/AView Earnings Details
8/1/2013Q4 2013$0.77$0.79$24.56 billion$25.40 billionViewN/AView Earnings Details
5/2/2013Q3 2013$0.95$1.20$24.72 billion$24.60 billionViewN/AView Earnings Details
2/5/2013Q2 2013$0.86$0.93$24.61 million$22.75 millionViewN/AView Earnings Details
10/30/2012Q113$0.79$0.81$26.33 million$25.90 millionViewN/AView Earnings Details
8/2/2012$0.73$0.73ViewN/AView Earnings Details
5/3/2012$0.88$0.94ViewN/AView Earnings Details
2/2/2012$0.77$0.81ViewN/AView Earnings Details
10/27/2011$0.72$0.73ViewN/AView Earnings Details
8/4/2011$0.58$0.59ViewN/AView Earnings Details
4/28/2011$0.69$0.75ViewN/AView Earnings Details
2/3/2011$0.61$0.69ViewN/AView Earnings Details
10/28/2010Q1 2011$0.53$0.64ViewN/AView Earnings Details
8/5/2010Q4 2010$0.49$0.50ViewN/AView Earnings Details
4/29/2010Q3 2010$0.57$0.61ViewN/AView Earnings Details
1/28/2010Q2 2010$0.46$0.57ViewN/AView Earnings Details
11/5/2009Q1 2010$0.43$0.54ViewN/AView Earnings Details
8/18/2009Q4 2009$0.86$0.86ViewN/AView Earnings Details
4/30/2009Q3 2009$0.95$0.97ViewN/AView Earnings Details
2/5/2009Q2 2009$0.89$0.93ViewN/AView Earnings Details
10/29/2008Q1 2009$0.70$0.74ViewN/AView Earnings Details
8/7/2008Q4 2008$0.95$0.97ViewN/AView Earnings Details
5/1/2008Q3 2008$1.00$1.08ViewN/AView Earnings Details
1/29/2008Q2 2008$0.88$0.90ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Cardinal Health (NYSE:CAH) Dividend Information

Cardinal Health pays an annual dividend of $1.85 per share, with a dividend yield of 3.48%. CAH's next quarterly dividend payment will be made on Sunday, July 15. The company has grown its dividend for the last 13 consecutive years and is increasing its dividend by an average of 12.20% each year. Cardinal Health pays out 34.26% of its earnings out as a dividend.
Next Dividend:7/15/2018
Annual Dividend:$1.85
Dividend Yield:3.48%
Dividend Growth:12.20% (3 Year Average)
Payout Ratio(s):34.26% (Trailing 12 Months of Earnings)
37.68% (Based on This Year's Estimates)
34.77% (Based on Next Year's Estimates)
23.99% (Based on Cash Flow)
Track Record:13 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/9/2018Quarterly$0.47603.48%6/29/20187/2/20187/15/2018
2/7/2018quarterly$0.46242.95%3/29/20184/2/20184/15/2018
11/8/2017quarterly$0.46243.05%12/29/20171/2/20181/15/2018
8/9/2017quarterly$0.46242.75%9/29/201710/2/201710/15/2017
5/3/2017quarterly$0.46242.54%6/29/20177/3/20177/15/2017
2/2/2017quarterly$0.44892.4%3/30/20174/3/20174/15/2017
11/3/2016quarterly$0.44892.76%12/29/20161/3/20171/15/2017
8/8/2016quarterly$0.44892.14%9/29/201610/3/201610/15/2016
5/4/2016quarterly$0.44892.29%6/29/20167/1/20167/15/2016
2/2/2016quarterly$0.38702%3/30/20164/1/20164/15/2016
11/4/2015quarterly$0.38701.76%12/30/20151/4/20161/15/2016
8/5/2015quarterly$0.38701.83%9/29/201510/1/201510/15/2015
5/6/2015quarterly$0.38701.82%6/29/20157/1/20157/15/2015
2/3/2015quarterly$0.34251.62%3/30/20154/1/20154/15/2015
11/5/2014quarterly$0.34251.72%12/30/20141/2/20151/15/2015
8/6/2014quarterly$0.34251.96%9/29/201410/1/201410/15/2014
5/7/2014quarterly$0.34252.14%6/27/20147/1/20147/15/2014
2/5/2014quarterly$0.30251.83%3/28/20144/1/20144/15/2014
11/6/2013quarterly$0.30251.99%12/30/20131/2/20141/15/2014
8/7/2013quarterly$0.30252.35%9/27/201310/1/201310/15/2013
5/2/2013quarterly$0.30252.61%6/27/20137/1/20137/15/2013
2/6/2013quarterly$0.27502.46%3/27/20134/1/20134/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Cardinal Health (NYSE CAH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 91.69%
Insider Trading History for Cardinal Health (NYSE:CAH)
Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE CAH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Jon L GiacominCEOSell7,995$68.78$549,896.1063,043View SEC Filing  
2/14/2018Patricia MorrisonInsiderSell28,532$66.30$1,891,671.6036,157View SEC Filing  
1/22/2018Michael C KaufmannCEOSell18,586$73.90$1,373,505.40211,849View SEC Filing  
5/12/2017Jon L GiacominCEO of Cardinal Health's pharmaceutical segmentSell23,270$72.87$1,695,684.9055,440View SEC Filing  
2/10/2017George S BarrettChairmanSell217,994$77.23$16,835,676.62682,225View SEC Filing  
11/10/2016George S BarrettChairmanSell217,995$71.29$15,540,863.55682,226View SEC Filing  
8/18/2016Patricia MorrisonInsiderSell43,959$82.50$3,626,617.5099,662View SEC Filing  
8/18/2016Stuart G LawsSVPSell9,703$82.45$800,012.352,718View SEC Filing  
8/16/2016Jon L GiacominCEOSell47,251$82.77$3,910,965.2744,598View SEC Filing  
8/11/2016Craig S MorfordInsiderSell12,697$83.13$1,055,501.6190,811View SEC Filing  
8/10/2016Donald M Jr. CaseyCEOSell59,180$83.59$4,946,856.20164,803View SEC Filing  
8/10/2016George S BarrettChairmanSell250,000$83.63$20,907,500.00510,762View SEC Filing  
8/9/2016George S BarrettCEOSell129,818$83.76$10,873,555.68510,762View SEC Filing  
8/8/2016George S BarrettCEOSell20,428$83.75$1,710,845.00510,762View SEC Filing  
5/20/2016Carole S WatkinsInsiderSell84,617$77.33$6,543,432.61116,202View SEC Filing  
11/6/2015Falk T. StephenEVPSell30,085$87.66$2,637,251.1033,633View SEC Filing  
8/20/2015George S. BarrettCEOSell300,000$83.08$24,924,000.00406,134View SEC Filing  
5/12/2015Falk T StephenEVPSell39,428$86.12$3,395,539.36View SEC Filing  
5/11/2015George S BarrettCEOSell300,000$86.44$25,932,000.00View SEC Filing  
3/4/2015Colleen F ArnoldDirectorSell9,801$87.65$859,057.65View SEC Filing  
3/3/2015Richard C NotebaertDirectorSell9,801$88.20$864,448.20View SEC Filing  
2/20/2015Carole S WatkinsInsiderSell33,847$87.00$2,944,689.00View SEC Filing  
2/10/2015Carole S WatkinsInsiderSell50,770$85.00$4,315,450.00View SEC Filing  
2/10/2015George S BarrettCEOSell300,000$84.87$25,461,000.00View SEC Filing  
11/7/2014Mark R BlakeEVPSell24,668$79.50$1,961,106.00View SEC Filing  
9/5/2014Carole S WatkinsInsiderSell40,794$75.00$3,059,550.00View SEC Filing  
9/4/2014Michael C KaufmannCEOSell50,216$74.95$3,763,689.20View SEC Filing  
8/27/2014Jeffrey William HendersonCFOSell26,567$72.63$1,929,561.21View SEC Filing  
8/18/2014Jeffrey William HendersonCFOSell78,637$72.06$5,666,582.22View SEC Filing  
8/18/2014Mark R BlakeEVPSell4,782$72.15$345,021.30View SEC Filing  
8/18/2014Michael C KaufmannCEOSell6,833$72.06$492,385.98View SEC Filing  
8/8/2014Craig S MorfordInsiderSell43,359$70.03$3,036,430.77View SEC Filing  
8/8/2014Jeffrey William HendersonCFOSell118,093$69.72$8,233,443.96View SEC Filing  
7/24/2014Mark R BlakeEVPSell23,114$73.41$1,696,798.74View SEC Filing  
7/24/2014Stuart G LawsCAOSell21,266$72.50$1,541,785.00View SEC Filing  
7/14/2014Jeffrey William HendersonCFOSell23,632$70.65$1,669,600.80View SEC Filing  
5/19/2014Mark BlakeEVPSell4,703$66.50$312,749.5024,416View SEC Filing  
5/13/2014Mark BlakeEVPSell2,822$66.50$187,663.0029,119View SEC Filing  
5/7/2014Jeffrey William HendersonCFOSell27,031$63.83$1,725,388.73107,096View SEC Filing  
2/11/2014Mark BlakeEVPSell2,330$68.53$159,674.9031,941View SEC Filing  
2/11/2014Michael KaufmannCEOSell388,995$67.46$26,241,602.70115,969View SEC Filing  
2/10/2014George BarrettCEOSell200,000$66.64$13,328,000.00334,102View SEC Filing  
2/5/2014Gregory KennyDirectorSell18,175$65.39$1,188,463.2519,584View SEC Filing  
2/4/2014Carole WatkinsInsiderSell46,666$65.71$3,066,422.8653,544View SEC Filing  
2/4/2014Falk StephenEVPSell17,926$65.56$1,175,228.5624,239View SEC Filing  
2/4/2014Richard NotebaertDirectorSell10,727$65.68$704,549.3633,750View SEC Filing  
11/11/2013George BarrettCEOSell200,000$62.71$12,542,000.00334,102View SEC Filing  
9/11/2013Mark R BlakeEVPSell14,584$51.53$751,513.52View SEC Filing  
8/19/2013Mark BlakeEVPSell4,925$51.27$252,504.7530,641View SEC Filing  
8/16/2013Falk StephenEVPSell10,000$51.50$515,000.0034,239View SEC Filing  
8/15/2013Craig MorfordInsiderSell20,000$51.33$1,026,600.0081,554View SEC Filing  
8/13/2013George BarrettCEOSell75,000$52.09$3,906,750.00325,787View SEC Filing  
8/13/2013Jeffrey William HendersonCFOSell54,590$51.99$2,838,134.10167,390View SEC Filing  
8/8/2013Calvin DardenDirectorSell3,254$51.48$167,515.9218,131View SEC Filing  
8/5/2013Mark BlakeEVPSell29,166$51.53$1,502,923.9832,741View SEC Filing  
7/26/2013Jeffrey William HendersonCFOSell76,781$50.99$3,915,063.19View SEC Filing  
7/18/2013Jeffrey William HendersonCFOSell57,623$49.99$2,880,573.77View SEC Filing  
7/15/2013Jeffrey William HendersonCFOSell14,660$49.99$732,853.40View SEC Filing  
7/11/2013Jeffrey William HendersonCFOSell83,211$48.99$4,076,506.89View SEC Filing  
6/19/2013John F FinnDirectorSell11,070$48.51$537,005.70View SEC Filing  
5/28/2013Jean G SpauldingDirectorSell8,350$47.35$395,372.50View SEC Filing  
5/22/2013Richard C NotebaertDirectorSell3,197$48.10$153,775.70View SEC Filing  
5/20/2013Carole S WatkinsInsiderSell4,612$48.00$221,376.00View SEC Filing  
5/20/2013Jean G SpauldingDirectorSell1,666$47.90$79,801.40View SEC Filing  
11/1/2012Stuart G LawsCAOSell2,564$41.22$105,688.08View SEC Filing  
10/4/2012Jeffrey William HendersonCFOSell46,226$40.00$1,849,040.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cardinal Health (NYSE CAH) News Headlines

Source:
DateHeadline
Contrasting Cardinal Health (CAH) & Nu Skin Enterprises (NUS)Contrasting Cardinal Health (CAH) & Nu Skin Enterprises (NUS)
www.americanbankingnews.com - May 21 at 9:22 PM
$34.55 Billion in Sales Expected for Cardinal Health (CAH) This Quarter$34.55 Billion in Sales Expected for Cardinal Health (CAH) This Quarter
www.americanbankingnews.com - May 20 at 2:12 AM
 Analysts Anticipate Cardinal Health (CAH) to Post $1.00 Earnings Per Share Analysts Anticipate Cardinal Health (CAH) to Post $1.00 Earnings Per Share
www.americanbankingnews.com - May 18 at 7:29 PM
Did Cardinal Health Inc (NYSE:CAH) Create Value For Shareholders?Did Cardinal Health Inc (NYSE:CAH) Create Value For Shareholders?
finance.yahoo.com - May 18 at 6:08 PM
Trxade Group (TRXD) vs. Cardinal Health (CAH) Financial SurveyTrxade Group (TRXD) vs. Cardinal Health (CAH) Financial Survey
www.americanbankingnews.com - May 18 at 5:29 PM
Cardinal Health (CAH) Receives Average Recommendation of "Hold" from AnalystsCardinal Health (CAH) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 17 at 7:51 PM
Axway promotes CFO to lead global tech firm's transformationAxway promotes CFO to lead global tech firm's transformation
finance.yahoo.com - May 17 at 7:02 PM
Reviewing Nu Skin Enterprises (NUS) and Cardinal Health (CAH)Reviewing Nu Skin Enterprises (NUS) and Cardinal Health (CAH)
www.americanbankingnews.com - May 14 at 7:06 PM
Head to Head Contrast: PetIQ (PETQ) & Cardinal Health (CAH)Head to Head Contrast: PetIQ (PETQ) & Cardinal Health (CAH)
www.americanbankingnews.com - May 12 at 11:13 PM
Trump Strikes At PBMs, Insurers, Drugmakers With Plans To Lower Consumer PricesTrump Strikes At PBMs, Insurers, Drugmakers With Plans To Lower Consumer Prices
finance.yahoo.com - May 11 at 6:07 PM
Ad Com June 12 for Cardinals InCraft stent; shares ahead 6%Ad Com June 12 for Cardinal's InCraft stent; shares ahead 6%
seekingalpha.com - May 10 at 6:06 PM
Cardinal Health (CAH) Raises Quarterly Dividend 3% to $0.4763; 3.6% YieldCardinal Health (CAH) Raises Quarterly Dividend 3% to $0.4763; 3.6% Yield
www.streetinsider.com - May 10 at 8:17 AM
May Top Undervalued Utilities Stocks To Look Out ForMay Top Undervalued Utilities Stocks To Look Out For
finance.yahoo.com - May 9 at 8:11 AM
Drug supply firm execs say they didn't cause opioids crisisDrug supply firm execs say they didn't cause opioids crisis
finance.yahoo.com - May 8 at 5:47 PM
Cardinal Health (CAH) Downgraded by Zacks Investment ResearchCardinal Health (CAH) Downgraded by Zacks Investment Research
www.americanbankingnews.com - May 8 at 3:33 PM
Lawmakers: Drug distributors missed suspicious opioid salesLawmakers: Drug distributors missed suspicious opioid sales
marketbeat.com - May 8 at 11:39 AM
[$$] Opioid Shipments to Small Towns Come Under Spotlight at Hearing[$$] Opioid Shipments to Small Towns Come Under Spotlight at Hearing
finance.yahoo.com - May 8 at 8:09 AM
Hill panel probing opioids abuse targets distributor firmsHill panel probing opioids abuse targets distributor firms
finance.yahoo.com - May 8 at 8:09 AM
Cardinal Health Has Become AttractiveCardinal Health Has Become Attractive
seekingalpha.com - May 7 at 5:45 PM
Cardinal Health (CAH) PT Set at $61.00 by MizuhoCardinal Health (CAH) PT Set at $61.00 by Mizuho
www.americanbankingnews.com - May 7 at 2:57 PM
Edited Transcript of CAH earnings conference call or presentation 3-May-18 12:30pm GMTEdited Transcript of CAH earnings conference call or presentation 3-May-18 12:30pm GMT
finance.yahoo.com - May 7 at 8:14 AM
Cardinal Health (CAH) to Post FY2018 Earnings of $4.90 Per Share, William Blair ForecastsCardinal Health (CAH) to Post FY2018 Earnings of $4.90 Per Share, William Blair Forecasts
www.americanbankingnews.com - May 7 at 4:02 AM
Cardinal Health (CAH) Downgraded by TheStreetCardinal Health (CAH) Downgraded by TheStreet
www.americanbankingnews.com - May 6 at 12:11 PM
Cardinal Health (CAH) Given a $65.00 Price Target at Leerink SwannCardinal Health (CAH) Given a $65.00 Price Target at Leerink Swann
www.americanbankingnews.com - May 6 at 12:01 PM
Jefferies Group Analysts Give Cardinal Health (CAH) a $55.00 Price TargetJefferies Group Analysts Give Cardinal Health (CAH) a $55.00 Price Target
www.americanbankingnews.com - May 4 at 7:31 PM
Cardinal Health (CAH) Price Target Raised to $62.00Cardinal Health (CAH) Price Target Raised to $62.00
www.americanbankingnews.com - May 4 at 5:47 PM
Control Risk With Cardinal Health Hovering Around $50Control Risk With Cardinal Health Hovering Around $50
seekingalpha.com - May 4 at 5:41 PM
Cardinal Health (CAH) Misses on Earnings in Q3, Beats RevenueCardinal Health (CAH) Misses on Earnings in Q3, Beats Revenue
finance.yahoo.com - May 4 at 8:13 AM
Cardinal Health (CAH) Q3 2018 Results - Earnings Call TranscriptCardinal Health (CAH) Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 8:13 AM
Cardinal Health misses profit on Cordis woes, shares fallCardinal Health misses profit on Cordis woes, shares fall
www.reuters.com - May 4 at 8:13 AM
Cardinal Health Plunges After Negative Earnings RevisionCardinal Health Plunges After Negative Earnings Revision
www.thestreet.com - May 4 at 8:13 AM
Cardinal Health (CAH) Lowered to Sell at ValuEngineCardinal Health (CAH) Lowered to Sell at ValuEngine
www.americanbankingnews.com - May 3 at 10:05 PM
Cardinal Health Inc. 2018 Q3 - Results - Earnings Call SlidesCardinal Health Inc. 2018 Q3 - Results - Earnings Call Slides
seekingalpha.com - May 3 at 5:30 PM
Cardinal Health (CAH) Misses on Q3 Earnings, Lowers 18 ViewCardinal Health (CAH) Misses on Q3 Earnings, Lowers '18 View
www.nasdaq.com - May 3 at 5:30 PM
BRIEF-Cardinal Health Reports Q3 Non-GAAP Earnings Per Share $1.39BRIEF-Cardinal Health Reports Q3 Non-GAAP Earnings Per Share $1.39
www.reuters.com - May 3 at 5:30 PM
The Biggest Movers: Vulcan Erupts; Cardinal Health TumblesThe Biggest Movers: Vulcan Erupts; Cardinal Health Tumbles
finance.yahoo.com - May 3 at 5:30 PM
Tesla and AIG tumble while Kraft Heinz and Kellogg climbTesla and AIG tumble while Kraft Heinz and Kellogg climb
marketbeat.com - May 3 at 4:47 PM
Cardinal Health Inc Stock Craters on Q3 Earnings MissCardinal Health Inc Stock Craters on Q3 Earnings Miss
investorplace.com - May 3 at 1:24 PM
U.S. stocks sink again as banks and healthcare companies slideU.S. stocks sink again as banks and healthcare companies slide
www.latimes.com - May 3 at 11:58 AM
Cardinal Health shares drop 18% after drug distributor cuts forecastCardinal Health shares drop 18% after drug distributor cuts forecast
www.cnbc.com - May 3 at 11:16 AM
Cardinal Health (CAH) Updates FY18 Earnings GuidanceCardinal Health (CAH) Updates FY18 Earnings Guidance
www.americanbankingnews.com - May 3 at 10:06 AM
Cardinal Health misses by $0.12, beats on revenueCardinal Health misses by $0.12, beats on revenue
seekingalpha.com - May 3 at 8:09 AM
Cardinal: Fiscal 3Q Earnings SnapshotCardinal: Fiscal 3Q Earnings Snapshot
finance.yahoo.com - May 3 at 8:09 AM
Cardinal Health shares drop after Q3 profit miss, lower 2018 guidanceCardinal Health shares drop after Q3 profit miss, lower 2018 guidance
finance.yahoo.com - May 3 at 8:09 AM
Cardinal Health Reports Third-quarter Results for Fiscal Year 2018Cardinal Health Reports Third-quarter Results for Fiscal Year 2018
finance.yahoo.com - May 3 at 8:09 AM
Drug distributor Cardinal Healths quarterly profit missesDrug distributor Cardinal Health's quarterly profit misses
finance.yahoo.com - May 3 at 8:09 AM
$33.61 Billion in Sales Expected for Cardinal Health (CAH) This Quarter$33.61 Billion in Sales Expected for Cardinal Health (CAH) This Quarter
www.americanbankingnews.com - May 3 at 4:20 AM
PetIQ (PETQ) and Cardinal Health (CAH) Head-To-Head ComparisonPetIQ (PETQ) and Cardinal Health (CAH) Head-To-Head Comparison
www.americanbankingnews.com - May 2 at 1:08 AM
Cardinal Health urEssential Award Recognizes Laboratory Professors Distinguished CareerCardinal Health urEssential Award Recognizes Laboratory Professor's Distinguished Career
finance.yahoo.com - May 1 at 5:22 PM
$1.51 EPS Expected for Cardinal Health (CAH) This Quarter$1.51 EPS Expected for Cardinal Health (CAH) This Quarter
www.americanbankingnews.com - May 1 at 8:20 AM

SEC Filings

Cardinal Health (NYSE:CAH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cardinal Health (NYSE:CAH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cardinal Health (NYSE CAH) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.